School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Department of Neurosurgery, University of Kansas Medical Center, Kansas City, Kansas.
Oper Neurosurg (Hagerstown). 2019 Mar 1;16(3):374-382. doi: 10.1093/ons/opy099.
Hospital readmissions can be detrimental to patients and may interfere with the potential benefits of the therapeutic procedure. Government agencies have begun to focus on reducing readmissions; however, the etiology of readmissions is lacking.
To report the national rates, risk factors, and outcomes associated with 30- and 90-d readmissions following surgery for intractable epilepsy.
We queried the Nationwide Readmissions Database from January to September 2013 using International Classification of Diseases, Ninth Edition, Clinical Modification codes to identify all patients with intractable epilepsy, who underwent hemispherectomy (01.52), brain lobectomy (01.53), amydalohippocampectomy, or partial lobectomy (01.59). Predictor variables included epilepsy type, presurgical diagnostic testing, surgery type, medical complications, surgical complications, and discharge disposition.
In 1587 patients, the 30- and 90-d readmission rates were 11.5% and 16.8%, respectively. The most common reasons for readmission were persistent epilepsy, video electroencephalography monitoring, postoperative infection, and postoperative central nervous system complication. In multivariable analysis, risk factors associated with both 30- and 90-d readmission were Medicare payer status, lowest quartile of median income, depression, hemispherectomy, and postoperative complications (P < .05). The only unique predictor of 30-d readmission was small bedsize hospital (P = .001). Readmissions within 30 d were associated with longer length of stay (6.8 vs 5.8 d), greater costs ($18 660 vs $15 515), and increased adverse discharges (26.4% vs 21.8%).
Following epilepsy surgery, most readmissions that occurred within 30 d can be attributed to management of persistent epilepsy and predicted by Medicare payer status, depression, and complications. These data can assist the clinician in preventing readmissions and assist policy makers determine which admissions are potentially avoidable.
医院再入院可能对患者有害,并可能干扰治疗程序的潜在益处。政府机构已开始关注减少再入院率;然而,再入院的病因仍不清楚。
报告全国范围内与难治性癫痫手术后 30 天和 90 天再入院相关的比率、风险因素和结局。
我们使用国际疾病分类,第九版,临床修正代码,从 2013 年 1 月至 9 月在全国再入院数据库中查询了所有接受半脑切除术(01.52)、脑叶切除术(01.53)、杏仁核海马切除术或部分叶切除术(01.59)的难治性癫痫患者。预测变量包括癫痫类型、术前诊断性检查、手术类型、医疗并发症、手术并发症和出院处置。
在 1587 名患者中,30 天和 90 天的再入院率分别为 11.5%和 16.8%。再入院的最常见原因是持续性癫痫、视频脑电图监测、术后感染和术后中枢神经系统并发症。多变量分析显示,与 30 天和 90 天再入院相关的风险因素包括医疗保险支付者身份、中位数收入最低四分位数、抑郁症、半脑切除术和术后并发症(P<0.05)。唯一与 30 天再入院相关的独特预测因素是小床位数医院(P=0.001)。30 天内的再入院与住院时间延长(6.8 天 vs 5.8 天)、费用增加(18660 美元 vs 15515 美元)和不良出院率增加(26.4% vs 21.8%)相关。
癫痫手术后,大多数在 30 天内发生的再入院可归因于持续性癫痫的治疗,并可由医疗保险支付者身份、抑郁症和并发症预测。这些数据可以帮助临床医生预防再入院,并帮助政策制定者确定哪些入院是可以避免的。